Zurich Cantonal Bank’s Vaxcyte PCVX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.26M | Buy |
38,749
+9,114
| +31% | +$296K | ﹤0.01% | 1112 |
|
|
2025
Q1 | $1.12M | Buy |
29,635
+436
| +1% | +$16.5K | ﹤0.01% | 1099 |
|
|
2024
Q4 | $2.39M | Buy |
29,199
+7,888
| +37% | +$646K | 0.01% | 783 |
|
|
2024
Q3 | $2.44M | Buy |
21,311
+826
| +4% | +$94.4K | 0.01% | 740 |
|
|
2024
Q2 | $1.55M | Buy |
20,485
+2,139
| +12% | +$162K | 0.01% | 842 |
|
|
2024
Q1 | $1.25M | Buy |
18,346
+1,193
| +7% | +$81.5K | ﹤0.01% | 957 |
|
|
2023
Q4 | $1.08M | Buy |
17,153
+6,229
| +57% | +$391K | ﹤0.01% | 1028 |
|
|
2023
Q3 | $557K | Buy |
10,924
+1,233
| +13% | +$62.9K | ﹤0.01% | 1327 |
|
|
2023
Q2 | $484K | Buy |
9,691
+1,479
| +18% | +$73.9K | ﹤0.01% | 1371 |
|
|
2023
Q1 | $308K | Buy |
8,212
+798
| +11% | +$29.9K | ﹤0.01% | 1614 |
|
|
2022
Q4 | $356K | Buy |
7,414
+538
| +8% | +$25.8K | ﹤0.01% | 1458 |
|
|
2022
Q3 | $165K | Buy |
6,876
+2,012
| +41% | +$48.3K | ﹤0.01% | 1865 |
|
|
2022
Q2 | $106K | Sell |
4,864
-102
| -2% | -$2.22K | ﹤0.01% | 2195 |
|
|
2022
Q1 | $120K | Buy |
+4,966
| New | +$120K | ﹤0.01% | 2201 |
|